1. Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade. Issue 6 (14th July 2008) Authors: Cantaert, T; De Rycke, L; Mavragani, C P; Wijbrandts, C A; Niewold, T B; Niers, T; Vandooren, B; Veys, E M; Richel, D; Tak, P P; Crow, M K; Baeten, D Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 6(2009) Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Issue 12 (13th February 2008) Authors: Dastmalchi, M; Grundtman, C; Alexanderson, H; Mavragani, C P; Einarsdottir, H; Helmers, S Barbasso; Elvin, K; Crow, M K; Nennesmo, I; Lundberg, I E Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 12(2008) Page Start: 1670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Complement activation and regulation in early and advanced stage osteoarthritis. (4th April 2011) Authors: Scott, J L; Scanzello, C R; Dragomir, C; Crow, M K Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis. (9th March 2010) Authors: Thurlings, R M; Boumans, M; Tekstra, J; Vos, K; van Westing, D M; van Baarsen, L G; Bos, C; Kirou, K A; Gerlag, D M; Crow, M K; Verweij, C L; Tak, P P Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗